4.6 Review

Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies

期刊

VIRUSES-BASEL
卷 13, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/v13071195

关键词

Crimean-Congo hemorrhagic fever virus; bunyavirus; tick-borne virus; antiviral strategies

类别

资金

  1. National Natural Science Foundation of China [31870162, 82161138003]
  2. National Key Research and Development Program of China [2018YFA0507202]
  3. Youth Innovation Promotion Association of Chinese Academy of Sciences

向作者/读者索取更多资源

Crimean-Congo hemorrhagic fever virus is a tick-borne pathogen that causes severe illness and has limited treatment options without FDA-approved vaccines or specific antiviral medications. The risk of transmission has increased due to climate change and globalization, highlighting the need for greater efforts in finding therapeutic approaches.
Crimean-Congo hemorrhagic fever virus (CCHFV) is a widespread, tick-borne pathogen that causes Crimean-Congo hemorrhagic fever (CCHF) with high morbidity and mortality. CCHFV is transmitted to humans through tick bites or direct contact with patients or infected animals with viremia. Currently, climate change and globalization have increased the transmission risk of this biosafety level (BSL)-4 virus. The treatment options of CCHFV infection remain limited and there is no FDA-approved vaccine or specific antivirals, which urges the identification of potential therapeutic targets and the design of CCHF therapies with greater effort. In this article, we discuss the current progress and some future directions in the development of antiviral strategies against CCHFV.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据